Following an application from AlzChem AG, submitted pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to creatine in combination with resistance training and improvement in muscle strength (Question No EFSA-Q-2015-00437 [EFSA Journal 2016;14(2):4400.]). The claim proposed by the applicant was worded as follows: ‘creatine contributes to the maintenance of muscle function in the elderly’.
Recital 7, Regulation (EU) 2017/672
In forcesince 7 Apr 2017